Credit Suisse Ag Ani Pharmaceuticals Inc Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Credit Suisse Ag holds 31,453 shares of ANIP stock, worth $1.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,453

Previous 31,453 -0.0%

Holding current value

$1.78 Million

Previous $1.73 Million 25.37%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$48.72 - $65.43 $261,382 - $351,031	5,365 Added 20.57%	31,453 $1.73 Million
Q3 2023 Nov 13, 2023	BUY	$50.28 - $64.61 $177,790 - $228,460	3,536 Added 15.68%	26,088 $1.51 Million
Q2 2023 Aug 11, 2023	BUY	$37.29 - $53.83 $190,738 - $275,340	5,115 Added 29.33%	22,552 $1.21 Million
Q1 2023 May 10, 2023	BUY	$37.61 - $45.72 $188 - $228	5 Added 0.03%	17,437 $692,000
Q4 2022 Feb 13, 2023	BUY	$31.9 - $41.95 $108,810 - $143,091	3,411 Added 24.33%	17,432 $701,000
Q3 2022 Nov 10, 2022	BUY	$29.83 - $38.01 $2,088 - $2,660	70 Added 0.5%	14,021 $450,000
Q2 2022 Aug 12, 2022	SELL	$23.09 - $33.46 $17,271 - $25,028	-748 Reduced 5.09%	13,951 $414,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $5,274 - $9,241	-196 Reduced 1.32%	14,699 $413,000
Q4 2021 Feb 14, 2022	SELL	$32.97 - $56.85 $416,938 - $718,925	-12,646 Reduced 45.92%	14,895 $688,000
Q3 2021 Nov 12, 2021	SELL	$26.48 - $35.99 $57,382 - $77,990	-2,167 Reduced 7.29%	27,541 $904,000
Q2 2021 Aug 16, 2021	BUY	$31.86 - $38.6 $89,144 - $108,002	2,798 Added 10.4%	29,708 $1.04 Million
Q1 2021 May 14, 2021	SELL	$28.4 - $36.14 $119,251 - $151,751	-4,199 Reduced 13.5%	26,910 $972,000
Q4 2020 Feb 12, 2021	BUY	$23.69 - $31.47 $79,622 - $105,770	3,361 Added 12.11%	31,109 $904,000
Q3 2020 Nov 13, 2020	SELL	$26.38 - $33.1 $399,920 - $501,796	-15,160 Reduced 35.33%	27,748 $782,000
Q2 2020 Aug 12, 2020	BUY	$29.93 - $50.1 $789,852 - $1.32 Million	26,390 Added 159.77%	42,908 $1.39 Million
Q1 2020 May 13, 2020	BUY	$30.35 - $67.14 $247,231 - $546,922	8,146 Added 97.3%	16,518 $672,000
Q4 2019 Feb 12, 2020	BUY	$55.65 - $79.83 $86,257 - $123,736	1,550 Added 22.72%	8,372 $517,000
Q3 2019 Nov 12, 2019	BUY	$64.7 - $85.39 $17,663 - $23,311	273 Added 4.17%	6,822 $497,000
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $47,506 - $57,622	-701 Reduced 9.67%	6,549 $538,000
Q1 2019 May 14, 2019	SELL	$45.83 - $70.54 $18,652 - $28,709	-407 Reduced 5.32%	7,250 $512,000
Q4 2018 Feb 13, 2019	BUY	$41.17 - $56.44 $65,501 - $89,796	1,591 Added 26.23%	7,657 $344,000
Q3 2018 Nov 13, 2018	SELL	$52.95 - $71.34 $137,299 - $184,984	-2,593 Reduced 29.95%	6,066 $343,000
Q2 2018 Aug 14, 2018	BUY	$56.38 - $68.08 $114,338 - $138,066	2,028 Added 30.58%	8,659 $578,000
Q1 2018 May 15, 2018	SELL	$56.98 - $72.41 $50,598 - $64,300	-888 Reduced 11.81%	6,631 $385,000
Q4 2017 Feb 14, 2018	SELL	$53.3 - $74.56 $220,448 - $308,380	-4,136 Reduced 35.49%	7,519 $485,000
Q3 2017 Nov 14, 2017	BUY	$43.46 - $52.49 $257,326 - $310,793	5,921 Added 103.26%	11,655 $612,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,734	5,734 $269,000

Others Institutions Holding ANIP

# of Institutions

211

Shares Held

18.8M

Call Options Held

11.7K

Put Options Held

10.5K

View Full List

About ANI PHARMACEUTICALS INC

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

More about ANIP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account